Patient Colloquium on Alzheimer's Disease, Prevention, Diagnosis and Therapy UKB NewsRoom 2

Patient Colloquium on Alzheimer's Disease, Prevention, Diagnosis and Therapy UKB NewsRoom

10/17/2019, from 6:00 pm

Aid against oblivion
A patient colloquium on the cause, prevention, diagnosis and therapy of Alzheimer's disease

As part of the regular "Medical Medicine for You – Mid-Life" Patient Colloquium, Bonn University Hospital invites you to an information evening in collaboration with General-Anzeiger Bonn. Under the motto "Prevention, diagnosis and treatment of dementia", the lectures will give an overview of the causes, prevention, diagnosis and treatment options of Alzheimer's disease, the most common form of dementia. The free event will take place on Thursday, October 17, starting at 6pm in the Biomedical Center (BMZ) classroom, Venusberg-Campus 1.

Germany's intellectual capacity loss is currently affecting 1.6 million mostly elderly people – and it's on the rise. The most common cause of dementia is Alzheimer's disease. In this neurodegenerative disease, protein deposition leads to loss of nerve cells in the brain. This breakdown begins as early as 20 years before the first symptoms appear – such as loss of spatial and temporal orientation, limited memory, or personality changes.

The cure for Alzheimer's is now out of sight

Existing treatment options may not cure dementia, but may delay its progression. But the incentive to find a cure for Alzheimer's is great. Even after the failure of therapeutic approaches to prevent the formation of causative protein deposits, there are many other treatment ideas to explore. "It is important to develop better therapies and test them in studies. Because no medication currently available can stop the disease, "says Anja Schneider, MD, PhD, director of gerontopsychiatry at Bonn University Hospital. Therefore, prevention and early diagnosis become even more important in the next few years.

Together with prof. Schneider, prof. Dr. Honey. Dr. Monique Breteler, Director of the Rhineland Study at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, and Private Dr. Med. Klaus Fließbach, Senior Physician at the Department of Neurodegenerative Diseases and Gerontological Psychiatry at Bonn University Hospital, will present an overview of the causes, prevention, diagnosis and treatment options of Alzheimer's at the briefing. Among other things, three experts are exploring the following questions: "Is early diagnosis, i.e. before the onset of first symptoms, reasonable and ethically acceptable outside the context of the study?", "How to prevent Alzheimer's disease?", "What therapeutic options are available?", " Why are there no better therapies? "," What have we learned from the failure of previous therapy studies? " And "What therapies might come in the future?". After the lecture, there is an opportunity to ask the lecturers questions.

Media Contact:
Prof. Anja Schneider
Director of Gerontopsychiatry
Department of Neurodegenerative Diseases and Gerontopsychiatry, University Hospital Bonn
German Center for Neurodegenerative Diseases Bonn (DZNE)
Phone: 0228 / 287-15715
Email: Anja.Schneider@ukbonn.de

Prof. Dr. Monique M. B. Breteler
Rhineland Study / Director of Population Research
German Center for Neurodegenerative Diseases (DZNE)
Phone: 0228 / 43302-929
Email: monique.breteler@dzne.de

PD Dr. Klaus Fliessbach
Department of Neurodegenerative Diseases and University Hospital Gerontopsychiatry Bonn
Phone: 0228 / 287-15715
Email: Klaus.Fliessbach@ukbonn.de